Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price on May 14, 2025
Allakos Stock Forecast
ALLK's stock price has decreased by -73.02% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Allakos stock had an average target of $2.00, with a low estimate of $1.00 and a high estimate of $3.00.
Price Target: $2.00 (+507.72%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for Allakos stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
from 7.55M
Revenue Next Year
n/a
EPS This Year
-0.62
from -1.30
EPS Next Year
-0.23
from -0.62
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.05 | |||
| Avg | -0.62 | -0.23 | |||
| Low | -0.74 | -0.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |